Comparator sourcing is a bridge between two very different supply chains: Clinical and Commercial. Due to the growing cost of therapeutics, driven up by competitive pressures of biosimilar drugs, this bridge can be complex and heavily impacting the budget of your clinical studies. Access to industry expertise, market intelligence, sourcing networks and world leading services is important to optimize your trial.
A few general questions to start with:
These and many more questions can be answered by our dedicated and global team of Comparator Sourcing Specialists that consult, assist and understand your sourcing needs. Along with our global footprint we guarantee product integrity and quality assurance by limiting supply chain steps.
Interested in learning more about comparator sourcing?
Download our recent whitepaper that provides insights into the changing comparator sourcing landscape, focusing specifically on the instrumental role the Bolar exemption plays in the shift away from dependence on innovators for clinical supplies. Thermo Fisher's Comparator team has the required expertise to leverage the Bolar exemption, providing clients early access to generic / biosimilar drugs.